Abstract
This IDC Buyer Case Study describes the adoption, deployment, and utilization
of business analytics software among the Pfizer operational employees who are
focused on chemistry informatics and biological research. This Buyer Case Study
discusses the factors that drove Pfizer to consolidate to fewer licensed
software components (not necessarily fewer providers) and the benefits it
received from such a move. It examines Pfizer' s vision for the future of the
software it delivers to its research employees.